Yayın:
Chronic changes developing in the hydronephrotic and contralateral kidneys during unilateral ureteral obstruction in rats

dc.contributor.authorKutlu, Tuncer
dc.contributor.authorKaya, Ufuk
dc.contributor.authorYurtal, Ziya
dc.contributor.authorGüvenç, Mehmet
dc.contributor.authorÖzkan, Hüseyin
dc.contributor.authorEtyemez, Muhammed
dc.contributor.authorAlakuş, İbrahim
dc.contributor.authorKeçeli, Hasan Hüseyin
dc.date.accessioned2026-01-04T21:55:20Z
dc.date.issued2025-04-22
dc.description.abstractAnimal models of chronic kidney disease are important experimental tools used to validate new mechanisms and potential innovations, as well as to investigate therapeutic interventions before clinical trials in humans. This study aimed to determine the chronic changes occurring in the obstructed kidneys (OK) and the contralateral (CL) kidneys in unilateral ureteral obstruction (UUO) in rats.In the study, three groups (n:6) were formed. It was observed that dilated tubules decreased at 28 days compared to 14 days, while mononuclear cell infiltration and fibrosis increased. In the CL kidneys, glutathione (GSH) was lower compared to the control group (CG) at 14 days; at 28 days, malondialdehyde (MDA) was elevated, and GSH and catalase (CAT) levels were reduced. Nuclear factor erythroid 2-related factor 2 (NRF-2) protein expression was lower in the OK compared to the CL kidneys at both 14 and 28 days. NRF-2 gene expression was lower in the OK only at 28 days compared to the CG. However, in the CL kidneys, NRF-2 gene expression was higher at both 14 and 28 days compared to the CG. Cyclooxygenase-2 (COX-2) protein levels showed a significant increase in both the OK and CL kidneys at 14 days. COX-2 gene expression increased in the OK at 14 days compared to the CG. BAX protein levels were lower in the OK at 28 days compared to both the CG and CL kidneys. BCL-2 protein levels were lower in the OK compared to the CL kidneys at both 14 and 28 days.This study has identified changes in both the OK and CL kidneys, providing significant data for potential therapeutic, supportive, or protective research aimed at treating these kidneys.
dc.description.urihttps://doi.org/10.1007/s11033-025-10486-3
dc.description.urihttps://pubmed.ncbi.nlm.nih.gov/40261471
dc.identifier.doi10.1007/s11033-025-10486-3
dc.identifier.eissn1573-4978
dc.identifier.issn0301-4851
dc.identifier.openairedoi_dedup___::9920855b94c41945f95f5e732e45776b
dc.identifier.orcid0000-0002-4805-0993
dc.identifier.orcid0000-0001-5753-8985
dc.identifier.pubmed40261471
dc.identifier.scopus2-s2.0-105003135916
dc.identifier.urihttps://hdl.handle.net/20.500.12597/42623
dc.identifier.volume52
dc.language.isoeng
dc.publisherSpringer Science and Business Media LLC
dc.relation.ispartofMolecular Biology Reports
dc.rightsCLOSED
dc.subjectMale
dc.subjectNF-E2-Related Factor 2
dc.subjectHydronephrosis
dc.subjectKidney
dc.subjectCatalase
dc.subjectGlutathione
dc.subjectFibrosis
dc.subjectRats
dc.subjectDisease Models, Animal
dc.subjectOxidative Stress
dc.subjectCyclooxygenase 2
dc.subjectMalondialdehyde
dc.subjectAnimals
dc.subjectRenal Insufficiency, Chronic
dc.subjectUreteral Obstruction
dc.titleChronic changes developing in the hydronephrotic and contralateral kidneys during unilateral ureteral obstruction in rats
dc.typeArticle
dspace.entity.typePublication
local.api.response{"authors":[{"fullName":"Tuncer, Kutlu","name":"Tuncer","surname":"Kutlu","rank":1,"pid":null},{"fullName":"Ufuk, Kaya","name":"Ufuk","surname":"Kaya","rank":2,"pid":{"id":{"scheme":"orcid","value":"0000-0002-4805-0993"},"provenance":null}},{"fullName":"Ziya, Yurtal","name":"Ziya","surname":"Yurtal","rank":3,"pid":null},{"fullName":"Mehmet, Güvenç","name":"Mehmet","surname":"Güvenç","rank":4,"pid":null},{"fullName":"Hüseyin, Özkan","name":"Hüseyin","surname":"Özkan","rank":5,"pid":{"id":{"scheme":"orcid","value":"0000-0001-5753-8985"},"provenance":null}},{"fullName":"Muhammed, Etyemez","name":"Muhammed","surname":"Etyemez","rank":6,"pid":null},{"fullName":"İbrahim, Alakuş","name":"İbrahim","surname":"Alakuş","rank":7,"pid":null},{"fullName":"Hasan Hüseyin, Keçeli","name":"Hasan Hüseyin","surname":"Keçeli","rank":8,"pid":null}],"openAccessColor":null,"publiclyFunded":false,"type":"publication","language":{"code":"eng","label":"English"},"countries":null,"subjects":[{"subject":{"scheme":"keyword","value":"Male"},"provenance":null},{"subject":{"scheme":"keyword","value":"NF-E2-Related Factor 2"},"provenance":null},{"subject":{"scheme":"keyword","value":"Hydronephrosis"},"provenance":null},{"subject":{"scheme":"keyword","value":"Kidney"},"provenance":null},{"subject":{"scheme":"keyword","value":"Catalase"},"provenance":null},{"subject":{"scheme":"keyword","value":"Glutathione"},"provenance":null},{"subject":{"scheme":"keyword","value":"Fibrosis"},"provenance":null},{"subject":{"scheme":"keyword","value":"Rats"},"provenance":null},{"subject":{"scheme":"keyword","value":"Disease Models, Animal"},"provenance":null},{"subject":{"scheme":"keyword","value":"Oxidative Stress"},"provenance":null},{"subject":{"scheme":"keyword","value":"Cyclooxygenase 2"},"provenance":null},{"subject":{"scheme":"keyword","value":"Malondialdehyde"},"provenance":null},{"subject":{"scheme":"keyword","value":"Animals"},"provenance":null},{"subject":{"scheme":"keyword","value":"Renal Insufficiency, Chronic"},"provenance":null},{"subject":{"scheme":"keyword","value":"Ureteral Obstruction"},"provenance":null}],"mainTitle":"Chronic changes developing in the hydronephrotic and contralateral kidneys during unilateral ureteral obstruction in rats","subTitle":null,"descriptions":["Animal models of chronic kidney disease are important experimental tools used to validate new mechanisms and potential innovations, as well as to investigate therapeutic interventions before clinical trials in humans. This study aimed to determine the chronic changes occurring in the obstructed kidneys (OK) and the contralateral (CL) kidneys in unilateral ureteral obstruction (UUO) in rats.In the study, three groups (n:6) were formed. It was observed that dilated tubules decreased at 28 days compared to 14 days, while mononuclear cell infiltration and fibrosis increased. In the CL kidneys, glutathione (GSH) was lower compared to the control group (CG) at 14 days; at 28 days, malondialdehyde (MDA) was elevated, and GSH and catalase (CAT) levels were reduced. Nuclear factor erythroid 2-related factor 2 (NRF-2) protein expression was lower in the OK compared to the CL kidneys at both 14 and 28 days. NRF-2 gene expression was lower in the OK only at 28 days compared to the CG. However, in the CL kidneys, NRF-2 gene expression was higher at both 14 and 28 days compared to the CG. Cyclooxygenase-2 (COX-2) protein levels showed a significant increase in both the OK and CL kidneys at 14 days. COX-2 gene expression increased in the OK at 14 days compared to the CG. BAX protein levels were lower in the OK at 28 days compared to both the CG and CL kidneys. BCL-2 protein levels were lower in the OK compared to the CL kidneys at both 14 and 28 days.This study has identified changes in both the OK and CL kidneys, providing significant data for potential therapeutic, supportive, or protective research aimed at treating these kidneys."],"publicationDate":"2025-04-22","publisher":"Springer Science and Business Media LLC","embargoEndDate":null,"sources":["Crossref"],"formats":null,"contributors":null,"coverages":null,"bestAccessRight":{"code":"c_14cb","label":"CLOSED","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"Molecular Biology Reports","issnPrinted":"0301-4851","issnOnline":"1573-4978","issnLinking":null,"ep":null,"iss":null,"sp":null,"vol":"52","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::9920855b94c41945f95f5e732e45776b","originalIds":["10486","10.1007/s11033-025-10486-3","50|doiboost____|9920855b94c41945f95f5e732e45776b","40261471"],"pids":[{"scheme":"doi","value":"10.1007/s11033-025-10486-3"},{"scheme":"pmid","value":"40261471"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":0,"influence":2.5349236e-9,"popularity":2.8669784e-9,"impulse":0,"citationClass":"C5","influenceClass":"C5","impulseClass":"C5","popularityClass":"C5"}},"instances":[{"pids":[{"scheme":"doi","value":"10.1007/s11033-025-10486-3"}],"license":"Springer Nature TDM","type":"Article","urls":["https://doi.org/10.1007/s11033-025-10486-3"],"publicationDate":"2025-04-22","refereed":"peerReviewed"},{"pids":[{"scheme":"pmid","value":"40261471"}],"alternateIdentifiers":[{"scheme":"doi","value":"10.1007/s11033-025-10486-3"}],"type":"Article","urls":["https://pubmed.ncbi.nlm.nih.gov/40261471"],"publicationDate":"2025-04-22","refereed":"nonPeerReviewed"}],"isGreen":false,"isInDiamondJournal":false}
local.import.sourceOpenAire
local.indexed.atScopus
local.indexed.atPubMed

Dosyalar

Koleksiyonlar